Replies to post #8142 on Cytodyn Inc (CYDY)

[jboatswain]

I made a mistake of staying through the data for HTBX. I lost a chunk of money on it. I won't go back to HTBX until they finish P2 with COMpact platform in NSCLC. That will take them another two years. That's the story.

I see no major differences between OTC biotech and NASDAQ biotech when it comes to dilution, R/S, naked shorting, etc. I have a small position in CYDY. Interested in P3 data based on their P2. Interested in their mono as well. Before I increase my shares, I want to know their burn rate and their rate of dilution before P3 data. Inoviorulez talked about further dilution. Just poring through their SEC filings to get an idea.